10-Q Filing

AIM IMMUNOTECH INC. CIK: 946644 Q2 2012

Filing Information

Form Type	10-Q
Accession Number	`0001144204-12-043553`
Period End Date	20120630
Filing Date	20120808
Fiscal Year	2012
Fiscal Period	Q2
XBRL Instance	heb-20120630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 77 Income Statement 8 Cash Flow Statement 62 Stockholders Equity 2 Comprehensive Income 72

Balance Sheet 77 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value per share	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value per share	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.08M	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.17M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.10M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.92M	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Marketable securities- unrestricted	`AvailableForSaleSecuritiesCurrent`	$26.23M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities- unrestricted	`AvailableForSaleSecuritiesCurrent`	$19.44M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Marketable securities- restricted	`AvailableforsaleSecuritiesRestrictedCurrent`	$1.03M	USD	Point-in-time
Marketable securities- restricted	`AvailableforsaleSecuritiesRestrictedCurrent`	$7.34M	USD	Point-in-time
Inventories	`InventoryWorkInProcess`	$1.11M	USD	Point-in-time
Inventories	`InventoryWorkInProcess`	$787.00K	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Inventories	`InventoryWorkInProcess`	$897.00K	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseCurrent`	$531.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseCurrent`	$425.00K	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	136.22M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	135.64M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	135.64M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$31.79M	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	136.22M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$30.49M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.28M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.33M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$886.00K	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$863.00K	USD	Point-in-time
Marketable securities - unrestricted	`AvailableForSaleSecuritiesNoncurrent`	-	USD	Point-in-time
Marketable securities - unrestricted	`AvailableForSaleSecuritiesNoncurrent`	$1.96M	USD	Point-in-time
Marketable securities - restricted	`AvailableforsaleSecuritiesRestrictedNoncurrent`	-	USD	Point-in-time
Marketable securities - restricted	`AvailableforsaleSecuritiesRestrictedNoncurrent`	$2.08M	USD	Point-in-time
Construction in progress	`ConstructionInProgressGross`	$1.48M	USD	Point-in-time
Construction in progress	`ConstructionInProgressGross`	$4.35M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$71.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$65.00K	USD	Point-in-time
Total assets	`Assets`	$43.51M	USD	Point-in-time
Total assets	`Assets`	$41.11M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.80M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.68M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.64M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.17M	USD	Point-in-time
Margin account loan	`MarginAccountLoanLiability`	$4.33M	USD	Point-in-time
Margin account loan	`MarginAccountLoanLiability`	$1.70M	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	$49.00K	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	$50.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.07M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$7.36M	USD	Point-in-time
Long-term portion of capital lease	`CapitalLeaseObligationsNoncurrent`	$99.00K	USD	Point-in-time
Long-term portion of capital lease	`CapitalLeaseObligationsNoncurrent`	$73.00K	USD	Point-in-time
Redeemable warrants	`DerivativeLiabilitiesNoncurrent`	$380.00K	USD	Point-in-time
Redeemable warrants	`DerivativeLiabilitiesNoncurrent`	$144.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$7.58M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.55M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 136,221,041 and 135,642,303, respectively	`CommonStockValue`	$136.00K	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 136,221,041 and 135,642,303, respectively	`CommonStockValue`	$136.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$265.18M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$264.96M	USD	Point-in-time
Accumulated other comprehensive gain (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$266.00K	USD	Point-in-time
Accumulated other comprehensive gain (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-389.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-232.05M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-226.74M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$37.97M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$33.53M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$43.51M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$41.11M	USD	Point-in-time

Income Statement 8 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$37.97M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$33.53M	USD	Point-in-time
Stock issued for settlement of accounts payable	`StockIssuedForSettlementOfAccountsPayable`	$133.00K	USD	2 Qtrs
Equity based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$90.00K	USD	2 Qtrs
Equity based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$179.00K	USD	2 Qtrs
Net comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-4.65M	USD	2 Qtrs
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$37.97M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$33.53M	USD	Point-in-time

Cash Flow Statement 62 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-2.29M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.16M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-5.31M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-3.00M	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$296.00K	USD	2 Qtrs
Depreciation of property and equipment	`Depreciation`	$198.00K	USD	2 Qtrs
Amortization of patent and trademark rights	`AdjustmentForAmortization`	$5.00K	USD	2 Qtrs
Amortization of patent and trademark rights	`AdjustmentForAmortization`	$110.00K	USD	2 Qtrs
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$387.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$944.00K	USD	2 Qtrs
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$643.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$236.00K	USD	2 Qtrs
Equity-based compensation	`StockOptionPlanExpense`	$90.00K	USD	2 Qtrs
Equity-based compensation	`StockOptionPlanExpense`	$179.00K	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$211.00K	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$179.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpense`	$190.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpense`	$-106.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$256.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-140.00K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-676.00K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-476.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.48M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.80M	USD	2 Qtrs
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$381.00K	USD	2 Qtrs
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.21M	USD	2 Qtrs
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$28.00K	USD	2 Qtrs
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$51.00K	USD	2 Qtrs
Deposits on capital leases	`PaymentsToAcquireEquipmentOnLease`	$-7.00K	USD	2 Qtrs
Deposits on capital leases	`PaymentsToAcquireEquipmentOnLease`	$4.00K	USD	2 Qtrs
Maturities of short-term and long-term marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$7.22M	USD	2 Qtrs
Maturities of short-term and long-term marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$7.61M	USD	2 Qtrs
Purchase of short-term and long-term marketable securities	`PaymentsToAcquireMarketableSecurities`	$2.06M	USD	2 Qtrs
Purchase of short-term and long-term marketable securities	`PaymentsToAcquireMarketableSecurities`	$3.18M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$3.99M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.93M	USD	2 Qtrs
Payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$31.00K	USD	2 Qtrs
Payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$25.00K	USD	2 Qtrs
Proceeds from Margin Account Loan	`ProceedsFromMarginAccountLoan`	-	USD	2 Qtrs
Proceeds from Margin Account Loan	`ProceedsFromMarginAccountLoan`	$2.64M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-31.00K	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.62M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-840.00K	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-933.00K	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.08M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.17M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.10M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.92M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.08M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.17M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.10M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.92M	USD	Point-in-time
Issuance of common stock for accounts payable and accrued expenses	`IssuanceOfCommonStockForAccountsPayableAndAccruedExpenses`	$133.00K	USD	2 Qtrs
Issuance of common stock for accounts payable and accrued expenses	`IssuanceOfCommonStockForAccountsPayableAndAccruedExpenses`	$70.00K	USD	2 Qtrs
Equipment acquired by capital lease	`NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1`	-	USD	2 Qtrs
Equipment acquired by capital lease	`NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1`	$62.00K	USD	2 Qtrs
Unrealized gain on investments	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$636.00K	USD	2 Qtrs
Unrealized gain on investments	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$655.00K	USD	2 Qtrs
Redeemable warrants valuation adjustment	`AdjustmentOfWarrantsGrantedForServices`	$236.00K	USD	2 Qtrs
Redeemable warrants valuation adjustment	`AdjustmentOfWarrantsGrantedForServices`	$944.00K	USD	2 Qtrs
Cash paid for interest expense	`InterestExpense`	$12.00K	USD	2 Qtrs
Cash paid for interest expense	`InterestExpense`	$12.00K	USD	2 Qtrs

Stockholders Equity 2 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time

Comprehensive Income 72 line items

Line Item	Tag	Value	Unit	Period
Clinical treatment programs	`SalesRevenueGoodsNet`	$36.00K	USD	1 Quarter
Clinical treatment programs	`SalesRevenueGoodsNet`	$49.00K	USD	1 Quarter
Clinical treatment programs	`SalesRevenueGoodsNet`	$78.00K	USD	2 Qtrs
Clinical treatment programs	`SalesRevenueGoodsNet`	$121.00K	USD	2 Qtrs
Total Revenues	`Revenues`	$49.00K	USD	1 Quarter
Total Revenues	`Revenues`	$36.00K	USD	1 Quarter
Total Revenues	`Revenues`	$78.00K	USD	2 Qtrs
Total Revenues	`Revenues`	$121.00K	USD	2 Qtrs
Production/cost of goods sold	`CostOfRevenue`	$208.00K	USD	1 Quarter
Production/cost of goods sold	`CostOfRevenue`	$397.00K	USD	2 Qtrs
Production/cost of goods sold	`CostOfRevenue`	$488.00K	USD	2 Qtrs
Production/cost of goods sold	`CostOfRevenue`	$204.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.74M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.26M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.62M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.40M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.25M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.74M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.46M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.61M	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$3.68M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$3.28M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$7.50M	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$6.92M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-7.38M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-6.84M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-3.25M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-3.63M	USD	1 Quarter
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$12.00K	USD	2 Qtrs
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$6.00K	USD	1 Quarter
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$1.00K	USD	1 Quarter
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$12.00K	USD	2 Qtrs
Interest and other income	`OtherInterestAndDividendIncome`	$317.00K	USD	1 Quarter
Interest and other income	`OtherInterestAndDividendIncome`	$474.00K	USD	2 Qtrs
Interest and other income	`OtherInterestAndDividendIncome`	$520.00K	USD	2 Qtrs
Interest and other income	`OtherInterestAndDividendIncome`	$247.00K	USD	1 Quarter
Funds received from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	-	USD	1 Quarter
Funds received from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	-	USD	1 Quarter
Funds received from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$-2.27M	USD	2 Qtrs
Funds received from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$-1.33M	USD	2 Qtrs
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$387.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$944.00K	USD	2 Qtrs
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$643.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$236.00K	USD	2 Qtrs
Net loss	`ProfitLoss`	$-2.29M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.16M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-5.31M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-3.00M	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnInvestments`	$187.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnInvestments`	$-141.00K	USD	2 Qtrs
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnInvestments`	$-154.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnInvestments`	$584.00K	USD	2 Qtrs
Realized (loss) on marketable securities	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$-21.00K	USD	1 Quarter
Realized (loss) on marketable securities	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$-37.00K	USD	2 Qtrs
Realized (loss) on marketable securities	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$-495.00K	USD	2 Qtrs
Realized (loss) on marketable securities	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$-941.00K	USD	1 Quarter
Less: Premium amortization	`OtherComprehensiveIncomeLossReclassificationAdjustmentForWritedownOfSecuritiesIncludedInNetIncomeNetOfTax`	$48.00K	USD	1 Quarter
Less: Premium amortization	`OtherComprehensiveIncomeLossReclassificationAdjustmentForWritedownOfSecuritiesIncludedInNetIncomeNetOfTax`	$108.00K	USD	2 Qtrs
Less: Premium amortization	`OtherComprehensiveIncomeLossReclassificationAdjustmentForWritedownOfSecuritiesIncludedInNetIncomeNetOfTax`	-	USD	2 Qtrs
Less: Premium amortization	`OtherComprehensiveIncomeLossReclassificationAdjustmentForWritedownOfSecuritiesIncludedInNetIncomeNetOfTax`	-	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-2.79M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-3.39M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-4.65M	USD	2 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-3.80M	USD	2 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	2 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	2 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	135.32M	shares	2 Qtrs
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	135.97M	shares	1 Quarter
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	135.38M	shares	1 Quarter
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	135.88M	shares	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.